Description

[2Alpha(2S,3S,4S,6R),3Beta,5Alpha]-2,3-[[4-Acetoxytetrahydro-3-Hydroxy-6-Methyl-2H-Pyran-3,2-Diyl]Bis(Oxy)]-14-Hydroxy-19-Oxocard-20(22)-Enolide is a high-purity, complex steroidal lactone derivative, also known as a cardenolide analog. This compound is of significant interest for its potential as a key pharmaceutical intermediate in the synthesis of specialized active pharmaceutical ingredients (APIs). It is primarily utilized by research institutions and manufacturers in the pharmaceutical and life sciences sectors for advanced drug discovery and development programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel cardiotonic or anticancer agents.
• Biochemical Research: Used as a reference standard or probe in pharmacological studies targeting sodium-potassium ATPase enzymes.
• Organic Synthesis: Employed in complex multi-step syntheses to construct steroidal frameworks with specific stereochemistry.
• Drug Discovery: Acts as a lead compound or precursor for the development of new therapeutic molecules with potential cardiac activity.
• Academic Research: Utilized in universities and research institutes for studying structure-activity relationships (SAR) of steroidal compounds.

Basic Information

Product Name	[2Alpha(2S,3S,4S,6R),3Beta,5Alpha]-2,3-[[4-Acetoxytetrahydro-3-Hydroxy-6-Methyl-2H-Pyran-3,2-Diyl]Bis(Oxy)]-14-Hydroxy-19-Oxocard-20(22)-Enolide
CAS No.	36573-63-4
Molecular Formula	C30H42O11
Molecular Weight	578.65 g/mol
Synonyms	19-Oxocard-20(22)-enolide, 2,3-[(4-acetoxytetrahydro-3-hydroxy-6-methyl-2H-pyran-3,2-diyl)bis(oxy)]-14-hydroxy-, (2α,3β,5α)-; 3β,14-Dihydroxy-19-oxo-5α-card-20(22)-enolide 2,3-bis(4-acetoxy-3-hydroxy-6-methyltetrahydropyran-2-yloxy); Cardenolide derivative 36573-63-4; 19-Oxo-cardenolide glycoside analog; (2α,3β,5α)-14-Hydroxy-19-oxocard-20(22)-enolide 2,3-diyl bis(4-acetoxy-3-hydroxy-6-methyltetrahydropyran-2-yl) ether
EINECS	Contact for details

Quality Control

Our [2Alpha(2S,3S,4S,6R),3Beta,5Alpha]-2,3-[[4-Acetoxytetrahydro-3-Hydroxy-6-Methyl-2H-Pyran-3,2-Diyl]Bis(Oxy)]-14-Hydroxy-19-Oxocard-20(22)-Enolide is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the stringent requirements for research and pharmaceutical use. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Single Maximum Impurity	≤ 2.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.